Apollo Endosurgery, Inc.
APENDelisted Apr 4, 2023- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001251769
Apollo Endosurgery, Inc. was delisted on Apr 4, 2023; its insiders filed their last Form 4 on Apr 4, 2023; 90 institutions reported holding it in 13F filings for Q1 2023, worth $442.4M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Apollo Endosurgery, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 55 | 1 | 72 | +18 |
| Shares | 17.5M | 16.2K | 28.3M | +10.8M (+61.6%) |
| Value | $159.0M | $147.0K | $238.8M | +$80.0M (+50.4%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (27)
Institutions that held Apollo Endosurgery, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (9)
Institutions that held Apollo Endosurgery, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Invesco Ltd. | 294,649 | $2.67M |
| Raymond James & Associates | 28,392 | $257.0K |
| Kercheville Advisors, LLC | 10,682 | $97.0K |
| Barclays PLC | 6,772 | $61.0K |
| Tower Research Capital LLC (TRC) | 418 | $4.00K |
| Cutler Group LP | 500 | $4.00K |
| Brewin Dolphin Ltd | 1 | $9 |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 12 | $0 |
| Pacitti Group Inc. | 2 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held Apollo Endosurgery, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 16,203 | $147.0K |